𝔖 Bobbio Scriptorium

✦ LIBER ✦

Efficacy and Tolerability of a New Extended-Release Formulation of Nicotinic Acid in Korean Adults With Mixed Dyslipidemia: An 8-Week, Multicenter, Prospective, Randomized, Double-Blind, and Placebo-Controlled Trial

✍ Scribed by Sang-Hyun Kim; Min-Kyung Kim; Hae-Young Lee; Hyun-Jae Kang; Yong-Jin Kim; Byung-Joo Park; Hyo-Soo Kim

Book ID: 113544473
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 523 KB
Volume: 33
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2011.08.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of adding coen

Efficacy and tolerability of adding coenzyme A 400 U/d capsule to stable statin therapy for the treatment of patients with mixed dyslipidemia: an 8-week, multicenter, double-Blind, randomized, placebo-controlled study

✍ Lai, Jiangtao; Wu, Bifeng; Xuan, Tianming; Liu, Zhong; Chen, Junzhu 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 333 KB

Efficacy and tolerability of two formula

Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: An 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial

✍ Sang-Hyun Kim; Woo-Young Chung; Joo-Hee Zo; Myung-A Kim; Hyuk-Jae Chang; Young-S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Efficacy and safety profiles of a new S(

Efficacy and safety profiles of a new S(—)-amlodipine nicotinate formulation versus racemic amlodipine besylate in adult Korean patients with mild to moderate hypertension: An 8-week, multicenter, randomized, double-blind, double-dummy, parallel-group, phase III, noninferiority clinical trial

✍ Sung Ai Kim; Sungha Park; Namsik Chung; Do-Sun Lim; Joo-Young Yang; Byung-Hee Oh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Comparison of efficacy and tolerability

Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up noninferiority trial

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Efficacy and tolerability of a new formu

Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study

✍ Gavin R. Graff; Karen Maguiness; John McNamara; Ronald Morton; David Boyd; Katri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Efficacy and Tolerability of Fimasartan,

Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension

✍ Sang Eun Lee; Yong-Jin Kim; Hae-Young Lee; Han-Mo Yang; Chang-Gyu Park; Jae-Joon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 806 KB